BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19569609)

  • 1. [Tinea of the eyebrows. About six cases].
    Irimie M; Oanţa A; Anna-Adrien C; Fekete GL
    Oftalmologia; 2009; 53(1):81-4. PubMed ID: 19569609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species.
    Lipozencic J; Skerlev M; Orofino-Costa R; Zaitz VC; Horvath A; Chouela E; Romero G; Gourmala N; Paul C;
    Br J Dermatol; 2002 May; 146(5):816-23. PubMed ID: 12000378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tinea capitis caused by Microsporum canis treated with terbinafine.
    Aste N; Pau M
    Mycoses; 2004 Oct; 47(9-10):428-30. PubMed ID: 15504128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tinea capitis in adults.
    Aste N; Pau M; Biggio P
    Mycoses; 1996; 39(7-8):299-301. PubMed ID: 9009649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tinea capitis.
    Gupta AK; Summerbell RC
    Med Mycol; 2000 Aug; 38(4):255-87. PubMed ID: 10975696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terbinafine: efficacy and tolerability in young children with tinea capitis due to Microsporum canis.
    Silm H; Karelson M
    J Eur Acad Dermatol Venereol; 2002 May; 16(3):228-30. PubMed ID: 12195561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tinea capitis due to Microsporum audouinii in Malta.
    Vella Zahra L; Vella Briffa D
    Mycoses; 2003; 46(9-10):433-5. PubMed ID: 14622396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized double-blind comparative study of terbinafine for 1, 2 and 4 weeks in tinea capitis.
    Haroon TS; Hussain I; Aman S; Jahangir M; Kazmi AH; Sami AR; Nagi AH; Alvi KH; Iqbal N; Khan KA; Aziz R
    Br J Dermatol; 1996 Jul; 135(1):86-8. PubMed ID: 8776365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks.
    Filho ST; Cucé LC; Foss NT; Marques SA; Santamaria JR
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):141-6. PubMed ID: 9784040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing the therapeutic approach in tinea capitis of childhood with itraconazole.
    Möhrenschlager M; Schnopp C; Fesq H; Strom K; Beham A; Mempel M; Thomsen S; Brockow K; Wessner DB; Heidelberger A; Ruhdorfer S; Weigl L; Seidl HP; Ring J; Abeck D
    Br J Dermatol; 2000 Nov; 143(5):1011-5. PubMed ID: 11069511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trichoscopic signs of tinea capitis: a guide for selection of appropriate antifungal.
    Genedy RM; Sorour OA; Elokazy MAW
    Int J Dermatol; 2021 Apr; 60(4):471-481. PubMed ID: 33141453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of terbinafine and griseofulvin in the treatment of tinea capitis.
    Cáceres-Ríos H; Rueda M; Ballona R; Bustamante B
    J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):80-4. PubMed ID: 10607324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials.
    Fleece D; Gaughan JP; Aronoff SC
    Pediatrics; 2004 Nov; 114(5):1312-5. PubMed ID: 15520113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tinea capitis dermatophytes: susceptibility to antifungal drugs tested in vitro and in vivo.
    Mock M; Monod M; Baudraz-Rosselet F; Panizzon RG
    Dermatology; 1998; 197(4):361-7. PubMed ID: 9873175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinico-myocological profile of tinea capitis in North India and response to griseofulvin.
    Singal A; Rawat S; Bhattacharya SN; Mohanty S; Baruah MC
    J Dermatol; 2001 Jan; 28(1):22-6. PubMed ID: 11280460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter: Tinea capitis in infants in their first 2 years of life: A 12-year study and a review of the literature.
    Zaraa I; Hawilo A; Trojjet S; El Euch D; Mokni M; Ben Osman A
    Dermatol Online J; 2012 Jul; 18(7):16. PubMed ID: 22863638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis.
    Fuller LC; Smith CH; Cerio R; Marsden RA; Midgley G; Beard AL; Higgins EM; Hay RJ
    Br J Dermatol; 2001 Feb; 144(2):321-7. PubMed ID: 11251566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Griseofulvin and terbinafine in the treatment of tinea capitis in children.
    Rademaker M; Havill S
    N Z Med J; 1998 Feb; 111(1060):55-7. PubMed ID: 9539918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tinea capitis.
    Alvarez MS; Silverberg NB
    Cutis; 2006 Sep; 78(3):189-96. PubMed ID: 17036663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tinea capitis in adults in southern Spain. A 17-year epidemiological study.
    Lova-Navarro M; Gómez-Moyano E; Martínez Pilar L; Fernandez-Ballesteros MD; Godoy-Díaz DJ; Vera-Casaño A; Crespo-Erchiga V
    Rev Iberoam Micol; 2016; 33(2):110-3. PubMed ID: 26774593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.